|
Information For:
|
Revision BulletinRocuronium Bromide
In accordance with section 9.05(c) of the Rules and Procedures of the 2005–2010 Council of Experts, the Monograph Development—Psychiatrics and Psychoactives Expert Committee (MDPP) has revised the Rocuronium Bromide monograph in order to reflect the approved ANDAs as follows:
The Rocuronium Bromide Revision Bulletin text will be incorporated into USP 33-NF 28. Should you have any questions, please contact Ravi Ravichandran, Ph.D. (301–816–8330 or . Download the Rocuronium Bromide MonographWhat's NewChanges to the Dissolution Performance Verification Test (11/20/09) PF 35(6) Errata (10/30/09) New official Text for October: 15 Revisions Bulletins (10/30/09) Pending Standards for the month of October (10/30/09) PF 35(6), November-December 2009: Highlights and Stimuli Articles (10/23/09) Admission Criteria and Safety Classification for Dietary Supplements Guideline (10/22/09) Elemental Impurities Hot Topics information updated (10/13/09) General Chapter <1151> Pharmaceutical Dosage Forms (10/06/09) Heparin Hot Topics information updated (10/02/09)
Related Resources |
||||||||||||||||||||||||||||
Copyright © 2009 The United States Pharmacopeial Convention
|
|||||||||||||||||||||||||||||